RxNorm 847191 NDC Crossover
insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen Injector
Related NDC Codes to RxNorm Concept 847191
The following NDC codes crossover to the RxNorm Concept 847191. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
0169-2200 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-2201 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-3685 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Novo Nordisk | ACTIVE | |
0169-3696 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Novo Nordisk | ACTIVE | |
50090-2272 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-2273 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-4085 | Novolog Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | A-s Medication Solutions | ACTIVE | |
50090-4959 | .insulin Aspart Protamine And Insulin Aspart | Insulin Aspart | Injection, Suspension | Subcutaneous | A-s Medication Solutions | ACTIVE | |
54868-5201 | Novolog Mix 70/30 | Physicians Total Care, Inc. | INACTIVATED | ||||
54868-5327 | Novolog Mix 70/30 | Physicians Total Care, Inc. | INACTIVATED | ||||
70518-3236 | Insulin Aspart Protamine And Insulin Aspart Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Remedyrepack Inc. | ACTIVE | |
73070-200 | Insulin Aspart Protamine And Insulin Aspart Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Novo Nordisk Pharma, Inc. | ACTIVE | |
73070-203 | Insulin Aspart Protamine And Insulin Aspart Mix 70/30 | Insulin Aspart | Injection, Suspension | Subcutaneous | Novo Nordisk Pharma, Inc. | ACTIVE |